105
Participants
Start Date
January 11, 2016
Primary Completion Date
February 28, 2022
Study Completion Date
February 28, 2022
IRX-2
Method of Administration: Administered for 10 days as subcutaneous bilateral injections in the upper neck.
Cyclophosphamide
Method of Administration: Cyclophosphamide is administered once by IV
Indomethacin
Method of Administration: Indomethacin is administered orally for 21 days.
Zinc-containing multivitamin
Method of Administration: Zinc-containing multivitamin is administered orally for 21 days.
Omeprazole
Method of Administration: Omeprazole is administered orally for 21 days
Lenox Hill Hospital, New York
Monter Cancer Center - North Shore LIJ, New Hyde Park
Hospital of The University of Pennsylvania, Philadelphia
Emory University - Winship Cancer Center, Atlanta
University of Kentucky, Lexington
University of Michigan, Ann Arbor
Nebraska Methodist Hospital, Omaha
University of Arkansas For Medical Sciences, Little Rock
University of Oklahoma, Oklahoma City
Banner University Medical Center, Tucson
USC Norris Comprehensive Cancer Center, Los Angeles
Stanford University Medical Center, Stanford
Providence Cancer Center, Portland
Hospital Erasto Gaertner, Curitiba
Instituto Goiano de Oncologia e Hematologia (INGOH), Goiânia
Instituto do Câncer de Londrina, Londrina
Instituto Nacional do Cancer (INCA), Rio de Janeiro
Hospital de Base de São José do Rio Preto, São José do Vale do Rio Preto
Instituto Brasileiro de Controle do Câncer, São Paulo
Instituto do Cancer do Estado de São Paulo - ICESP, São Paulo
Sunnybrook Research Institute, Toronto
Queen Elizabeth University Hospital Glasgow, Glasgow
Lead Sponsor
Brooklyn ImmunoTherapeutics, LLC
INDUSTRY